{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T14:59:29Z","timestamp":1762009169138,"version":"build-2065373602"},"reference-count":22,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2019]]},"DOI":"10.1620\/tjem.247.35","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T22:27:32Z","timestamp":1547677652000},"page":"35-40","source":"Crossref","is-referenced-by-count":10,"title":["Once-Daily Low-Dose Cyclosporine A Treatment with Angiotensin Blockade for Long-Term Remission of Nephropathy in Frasier Syndrome"],"prefix":"10.1620","volume":"247","author":[{"given":"Yasushi","family":"Chiba","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Red Cross Sendai Hospital"},{"name":"Department of Pediatrics, Tohoku Rosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiyoko N.","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Red Cross Sendai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","unstructured":"B\u00fcscher, A.K., Beck, B.B., Melk, A., Hoefele, J., Kranz, B., Bamborschke, D., Baig, S., Lange-Sperandio, B., Jungraithmayr, T., Weber, L.T., Kemper, M.J., T\u00f6nshoff, B., Hoyer, P.F., Konrad, M. &amp; Weber, S.;  German Pediatric Nephrology Association (GPN)  (2016)  Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome.  <i>Clin. J. Am. Soc. Nephrol<\/i>., 11, 245-253."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Dong, L., Pietsch, S. &amp; Englert, C. (2015)  Towards an understanding of kidney diseases associated with WT1 mutations.  <i>Kidney Int<\/i>., 88, 684-690.","DOI":"10.1038\/ki.2015.198"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Eckel, J., Lavin, P.J., Finch, E.A., Mukerji, N., Burch, J., Gbadegesin, R., Wu, G., Bowling, B., Byrd, A., Hall, G., Sparks, M., Zhang, Z.S., Homstad, A., Barisoni, L., Birbaumer, L.,  et al. (2011)  TRPC6 enhances angiotensin II-induced albuminuria.  <i>J. Am. Soc. Nephrol<\/i>., 22, 526-535.","DOI":"10.1681\/ASN.2010050522"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Faul, C., Donnelly, M., Merscher-Gomez, S., Chang, Y.H., Franz, S., Delfgaauw, J., Chang, J.M., Choi, H.Y., Campbell, K.N., Kim, K., Reiser, J. &amp; Mundel, P. (2008)  The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.  <i>Nat. Med<\/i>., 14, 931-938.","DOI":"10.1038\/nm.1857"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Fujinaga, S., Hirano, D., Murakami, H., Ohtomo, Y., Shimizu, T. &amp; Kaneko, K. (2012)  Nephrotoxicity of once-daily cyclosporine A in minimal change nephrotic syndrome.  <i>Pediatr. Nephrol<\/i>., 27, 671-674.","DOI":"10.1007\/s00467-011-2076-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Gellermann, J., Stefanidis, C.J., Mitsioni, A. &amp; Querfeld, U. (2010)  Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations.  <i>Pediatr. Nephrol<\/i>., 25, 1285-1289.","DOI":"10.1007\/s00467-010-1468-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Hisano, S., Fukuma, Y., Segawa, Y., Niimi, K., Kaku, Y., Hatae, K., Saitoh, T., Takeshita, M. &amp; Iwasaki, H. (2008)  Clinicopathologic correlation and outcome of C1q nephropathy.  <i>Clin. J. Am. Soc. Nephrol<\/i>., 3, 1637-1643.","DOI":"10.2215\/CJN.00830208"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Kengne-Wafo, S., Massella, L., Diomedi-Camassei, F., Gianviti, A., Vivarelli, M., Greco, M., Stringini, G.R. &amp; Emma, F. (2009)  Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome.  <i>Clin. J. Am. Soc. Nephrol<\/i>., 4, 1409-1416.","DOI":"10.2215\/CJN.01520209"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Kriz, W., Shirato, I., Nagata, M., LeHir, M. &amp; Lemley, K.V. (2013)  The podocyte\u2019s response to stress: the enigma of foot process effacement.  <i>Am. J. Physiol. Renal Physiol<\/i>., 304, F333-347.","DOI":"10.1152\/ajprenal.00478.2012"},{"key":"10","unstructured":"Lehnhardt, A., Karnatz, C., Ahlenstiel-Grunow, T., Benz, K., Benz, M.R., Budde, K., B\u00fcscher, A.K., Fehr, T., Feldk\u00f6tter, M., Graf, N., H\u00f6cker, B., Jungraithmayr, T., Klaus, G., Koehler, B., Konrad, M.,  et al. (2015)  Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1.  <i>Clin. J. Am. Soc. Nephrol<\/i>., 10, 825-831."},{"key":"11","doi-asserted-by":"crossref","unstructured":"Li, J., Zhao, D., Ding, J., Xiao, H., Guan, N., Fan, Q. &amp; Zhang, H. (2007)  WT1 mutation and podocyte molecular expression in a Chinese Frasier syndrome patient.  <i>Pediatr. Nephrol<\/i>., 22, 2133-2136.","DOI":"10.1007\/s00467-007-0579-y"},{"key":"12","unstructured":"Lipska, B.S., Ranchin, B., Iatropoulos, P., Gellermann, J., Melk, A., Ozaltin, F., Caridi, G., Seeman, T., Tory, K., Jankauskiene, A., Zurowska, A., Szczepanska, M., Wasilewska, A., Harambat, J., Trautmann, A.,  et al.; PodoNet Consortium  (2014)  Genotype-phenotype associations in WT1 glomerulopathy.  <i>Kidney Int<\/i>., 85, 1169-1178."},{"key":"13","doi-asserted-by":"crossref","unstructured":"Litwin, M., Grenda, R., Sladowska, J. &amp; Antoniewicz, J. (2006)  Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors.  <i>Pediatr. Nephrol<\/i>., 21, 1716-1722.","DOI":"10.1007\/s00467-006-0223-2"},{"key":"14","unstructured":"Markowitz, G.S., Schwimmer, J.A., Stokes, M.B., Nasr, S., Seigle, R.L., Valeri, A.M. &amp; D\u2019Agati, V.D. (2003)  C1q nephropathy: a variant of focal segmental glomerulosclerosis.  <i>Kidney Int<\/i>., 64, 1232-1240."},{"key":"15","doi-asserted-by":"crossref","unstructured":"Niaudet, P. &amp; Gubler, M.C. (2006)  WT1 and glomerular diseases.  <i>Pediatr. Nephrol<\/i>., 21, 1653-1660.","DOI":"10.1007\/s00467-006-0208-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Nijenhuis, T., Sloan, A.J., Hoenderop, J.G., Flesche, J., van Goor, H., Kistler, A.D., Bakker, M., Bindels, R.J., de Boer, R.A., Moller, C.C., Hamming, I., Navis, G., Wetzels, J.F., Berden, J.H., Reiser, J.,  et al. (2011)  Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.  <i>Am. J. Pathol<\/i>., 179, 1719-1732.","DOI":"10.1016\/j.ajpath.2011.06.033"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Ruf, R.G., Schultheiss, M., Lichtenberger, A., Karle, S.M., Zalewski, I., Mucha, B., Everding, A.S., Neuhaus, T., Patzer, L., Plank, C., Haas, J.P., Ozaltin, F., Imm, A., Fuchshuber, A., Bakkaloglu, A. &amp; Hildebrandt, F.; APN Study Group (2004)  Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome.  <i>Kidney Int<\/i>., 66, 564-570.","DOI":"10.1111\/j.1523-1755.2004.00775.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Seeman, T., Pohl, M., Misselwitz, J. &amp; John, U. (2009)  Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.  <i>Kidney Blood Press. Res<\/i>., 32, 440-444.","DOI":"10.1159\/000266478"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Sinha, A., Sharma, S., Gulati, A., Sharma, A., Agarwala, S., Hari, P. &amp; Bagga, A. (2010)  Frasier syndrome: early gonadoblastoma and cyclosporine responsiveness.  <i>Pediatr. Nephrol<\/i>., 25, 2171-2174.","DOI":"10.1007\/s00467-010-1518-x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Suzuki, K., Oki, E., Tsuruga, K., Aizawa-Yashiro, T., Ito, E. &amp; Tanaka, H. (2010)  Benefits of once-daily administration of cyclosporine a for children with steroid-dependent, relapsing nephrotic syndrome.  <i>Tohoku J. Exp. Med<\/i>., 220, 183-186.","DOI":"10.1620\/tjem.220.183"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Vizjak, A., Ferluga, D., Rozic, M., Hvala, A., Lindic, J., Levart, T.K., Jurcic, V. &amp; Jennette, J.C. (2008)  Pathology, clinical presentations, and outcomes of C1q nephropathy.  <i>J. Am. Soc. Nephrol<\/i>., 19, 2237-2244.","DOI":"10.1681\/ASN.2007080929"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Wharram, B.L., Goyal, M., Wiggins, J.E., Sanden, S.K., Hussain, S., Filipiak, W.E., Saunders, T.L., Dysko, R.C., Kohno, K., Holzman, L.B. &amp; Wiggins, R.C. (2005)  Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.  <i>J. Am. Soc. Nephrol<\/i>., 16, 2941-2952.","DOI":"10.1681\/ASN.2005010055"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/247\/1\/247_35\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T04:50:51Z","timestamp":1547873451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/247\/1\/247_35\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.247.35","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"type":"print","value":"0040-8727"},{"type":"electronic","value":"1349-3329"}],"subject":[],"published":{"date-parts":[[2019]]}}}